Bizdata Insights Main Logo

Report suggests full government control over lifesaving drug price

Industry: Healthcare & Pharma, Pharma

A recent probe report on the overheated medicine market in Bangladesh has recommended implementing full government control over lifesaving drug prices and promoting the low-duty import of necessary raw materials. The report, comprising 17-point recommendations from a government intelligence agency, aims to address the escalating prices of medicines. Key suggestions include prioritizing the import of raw materials, reducing import hurdles faced by drug-makers during LC opening with banks, and streamlining the process for other supplies. The report also calls for intensified vigilance by the Directorate General of Drug Administration, prevention of unilateral price increases by pharmaceutical companies, and empowerment of the government’s drug administration to fix logical prices for a broader range of generics. These measures, if implemented, could help ensure affordable access to essential medicines for the people of Bangladesh. The report has been presented to the Prime Minister’s Office for further action and consideration.

Source for more details:

Related News

Meghna Bank Inks MoU with Ship Hospital

December 4, 2023

Meghna Bank PLC recently entered an MoU with Ship International Hospital at its Dhaka Head Office. The multi-specialized private hospital, operating under Japanese management, will offer exclusive year-round discounts on registrations to all Meghna Bank cardholders and employees.

Animal Health Industry Faces 30% Price Hike

November 28, 2023

Animal health companies in Bangladesh are facing challenges in importing raw materials due to difficulties in opening letters of credit (LCs) amid the ongoing dollar crisis.

ACI Seeks BSEC Approval for Tk600 Crore Sukuk

November 27, 2023

Advanced Chemical Industries (ACI) Limited has announced plans to raise Tk600 crore through the issuance of Sukuk instruments. The decision was made during a board meeting, and the company intends to issue Sukuk under a long-term fundraising program via a special purpose vehicle, pending approval from the Bangladesh Securities and

Bangladesh Ranks 40th in Global Inclusivity Index

November 26, 2023

Bangladesh ranks as the lowest among 40 countries in the Health Inclusivity Index's second phase, released by Economist Impact. In this phase, Bangladesh scores 26.6 out of 100, a decline from 30.8 in the initial phase.

Square Hospital Revenue Surge by 6%

November 25, 2023

Square Hospital in Bangladesh reported a revenue increase of over 6% for FY 2022–23, reaching Tk533 crore compared to Tk502 crore in FY 2021–2022. The net profit also rose by 12% year-on-year, reaching Tk37 crore in the outgoing FY. The surge is attributed to the prevalence of diseases, particularly dengue, contributing to

ADB Approves $336.5M Loan to Boost Vaccine Manufacturing

November 23, 2023

The Asian Development Bank (ADB) has approved a $336.5 million loan package to enhance Bangladesh's vaccine manufacturing capacity. The project aims to establish facilities for vaccine, therapeutic, and diagnostics manufacturing

Related News

Meghna Bank Inks MoU with Ship Hospital

December 4, 2023

Meghna Bank PLC recently entered an MoU with Ship International Hospital at its Dhaka Head Office. The multi-specialized private hospital, operating under Japanese management, will offer exclusive year-round discounts on registrations to all Meghna Bank cardholders and employees.

Animal Health Industry Faces 30% Price Hike

November 28, 2023

Animal health companies in Bangladesh are facing challenges in importing raw materials due to difficulties in opening letters of credit (LCs) amid the ongoing dollar crisis.

ACI Seeks BSEC Approval for Tk600 Crore Sukuk

November 27, 2023

Advanced Chemical Industries (ACI) Limited has announced plans to raise Tk600 crore through the issuance of Sukuk instruments. The decision was made during a board meeting, and the company intends to issue Sukuk under a long-term fundraising program via a special purpose vehicle, pending approval from the Bangladesh Securities and

Bangladesh Ranks 40th in Global Inclusivity Index

November 26, 2023

Bangladesh ranks as the lowest among 40 countries in the Health Inclusivity Index's second phase, released by Economist Impact. In this phase, Bangladesh scores 26.6 out of 100, a decline from 30.8 in the initial phase.

Square Hospital Revenue Surge by 6%

November 25, 2023

Square Hospital in Bangladesh reported a revenue increase of over 6% for FY 2022–23, reaching Tk533 crore compared to Tk502 crore in FY 2021–2022. The net profit also rose by 12% year-on-year, reaching Tk37 crore in the outgoing FY. The surge is attributed to the prevalence of diseases, particularly dengue, contributing to

ADB Approves $336.5M Loan to Boost Vaccine Manufacturing

November 23, 2023

The Asian Development Bank (ADB) has approved a $336.5 million loan package to enhance Bangladesh's vaccine manufacturing capacity. The project aims to establish facilities for vaccine, therapeutic, and diagnostics manufacturing

Shopping cart

0
image/svg+xml

No products in the cart.

Continue Shopping

BUSINESSMONITOR

Connect with


Dont Have Account? Please register Here